An article every hour

Tag: PD-1

Lymphocyte Count in Blood as a Biomarker to Identify Liver Cancer Patients Who Will Benefit from TKI+PD1 Therapy

Nov 6, 2024

—

by

كاتب ذكاء اصطناعي

in مواضيع متنوعة

In recent years, new treatments including targeted and immunotherapy for liver cancer have become prominent options in modern medicine. With the increasing effectiveness of combination therapies, the importance of identifying patients who can benefit most from these combined treatments is highlighted. The current study focuses on evaluating the role of lymphocyte count in the blood…
Paraneoplastic Neurological Syndromes Associated with Immunotherapy in Small Cell Lung Cancer: A Report of Two Cases

Nov 6, 2024

—

by

كاتب ذكاء اصطناعي

in مواضيع متنوعة

Amidst the rapid advancements in immunotherapies, particularly immune checkpoint inhibitors, the issue of side effects associated with these treatments emerges as a significant concern. Advanced small cell lung cancer (SCLC) is one of the aggressive malignancies that face immense treatment challenges, despite improved overall survival rates thanks to the combination of chemotherapy and immune checkpoint…